Key stats
About MIRAE ASSET TIGER KOSDAQ150BIOTECH ETF
Home page
Inception date
Dec 14, 2016
Replication method
Physical
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
Mirae Asset Global Investments Co., Ltd.
ISIN
KR7261070007
This ETF seeks investment results that corresponds generally to the price and yield performance, before fees and expenses, of the KOSDAQ 150 Bio technology Index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.45%
Health Technology91.49%
Consumer Non-Durables1.89%
Process Industries1.76%
Technology Services1.66%
Health Services1.16%
Electronic Technology1.09%
Distribution Services0.41%
Bonds, Cash & Other0.55%
Cash0.55%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
261070 invests in stocks. The fund's major sectors are Health Technology, with 91.49% stocks, and Consumer Non-Durables, with 1.89% of the basket. The assets are mostly located in the Asia region.
261070 top holdings are ALTEOGEN Inc. and Peptron, Inc., occupying 20.36% and 11.68% of the portfolio correspondingly.
261070 last dividends amounted to 40.00 KRW. The year before, the issuer paid 12.00 KRW in dividends, which shows a 70.00% increase.
261070 assets under management is 31.23 B KRW. It's risen 3.34% over the last month.
261070 fund flows account for 149.10 M KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, 261070 pays dividends to its holders with the dividend yield of 0.25%. The last dividend (May 7, 2025) amounted to 40.00 KRW. The dividends are paid annually.
261070 shares are issued by Mirae Asset Global Investments Co., Ltd. under the brand Tiger ETF. The ETF was launched on Dec 14, 2016, and its management style is Passive.
261070 expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
261070 follows the KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
261070 invests in stocks.
261070 price has fallen by −3.17% over the last month, and its yearly performance shows a 20.09% increase. See more dynamics on 261070 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 1.61% over the last month, showed a 12.51% increase in three-month performance and has increased by 27.96% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 1.61% over the last month, showed a 12.51% increase in three-month performance and has increased by 27.96% in a year.